mabl
AI-native low-code test automation with self-healing locators and automatic test generation.
Overview
mabl, founded in 2017 and based in Boston, is a cloud-native test automation platform built entirely around AI. Its key differentiator is autonomous test maintenance: when the UI changes, mabl's ML models automatically adapt tests without human intervention. mabl also offers auto-healing, intelligent waits, and AI-powered test failure analysis.
In 2026, mabl is recognised as one of the most reliable AI testing platforms with a 92% overall accuracy rate and 10% false positive rate in independent benchmarks. It is particularly popular with agile teams that release frequently and cannot afford manual test maintenance.
What it's used for
mabl is the best fit when:
- UI changes frequently: Self-healing reduces maintenance by 30-50% compared to traditional tools.
- Low-code approach is preferred: Tests are created via browser extension recording, not scripting.
- CI/CD integration is critical: Native integrations with GitHub, GitLab, Azure DevOps, and Jenkins.
- Cross-browser coverage needed: Runs on Chrome, Firefox, Safari, and Edge in the cloud.
Pros & Cons
Pros
- Industry-leading self-healing with 92% accuracy in benchmarks
- True low-code: record in browser, no programming required
- Cloud-native: no infrastructure to manage
- Excellent CI/CD integrations and pipeline analytics
- Strong visual regression testing capabilities
Cons
- SaaS-only: cannot run tests entirely on-premise
- Limited customisation for complex test scenarios
- Pricing is opaque — enterprise contracts only
- Not suitable for native mobile app testing
- Test creation can be slower than scripting for complex flows
Platforms & Integrations
mabl is a cloud-based SaaS platform. It tests web applications across Chrome, Firefox, Safari, and Edge. The mabl trainer browser extension runs on Chrome and Edge.
Pricing
| Tier | Cost | Includes |
|---|---|---|
| Starter | From ~$60/mo | Basic test creation, limited parallel execution |
| Growth | Custom | Unlimited tests, advanced analytics, API testing, visual regression |
| Enterprise | Custom | SSO, dedicated support, custom SLAs, on-premise runner option |
NZ Context
mabl is gaining traction in NZ SaaS companies with rapid release cycles. The mabl sales team has an APAC presence, though NZ-specific support is limited compared to Australia. For NZ teams evaluating AI testing, mabl is often compared against Testim and Functionize. mabl's self-healing is particularly valuable for teams with frequent UI redesigns.
Alternatives
- Testim — Similar AI self-healing but with more coding flexibility. Owned by Tricentis.
- Functionize — Enterprise-focused AI testing with NLP-based test creation.
- Playwright — Free, code-based alternative. No AI healing but much faster and more flexible.
When to choose mabl
A quick decision guide for NZ teams evaluating ai-powered test automation options.
| Choose mabl when… | Choose something else when… | Combine with… |
|---|---|---|
| Your team releases to production weekly or faster and test maintenance is eating sprint capacity | You need to test native iOS or Android apps — mabl is web-only and won't help here | Playwright for API and deep-integration tests that mabl's low-code recorder can't express |
| Your QA team is non-technical or junior — no scripting requirement removes a major hiring constraint | You have strict data residency or on-premise requirements (government, health) — mabl is SaaS-only with limited on-premise runner options | Postman or REST-Assured for API contract testing alongside mabl's UI layer |
| You want pipeline analytics — mabl surfaces flaky tests, slowest journeys, and failure trends across your CI runs | Your test scenarios are complex and highly conditional — Playwright or Cypress give you full code control that mabl's recorder can't match | Percy or Applitools for pixel-level visual regression if mabl's built-in visual checks aren't precise enough |
| You're buying rather than building — mabl's enterprise contract includes onboarding, CSM support, and uptime SLAs that open-source tools don't | Budget is tight — Cypress and Playwright are free, and mabl's enterprise pricing is opaque and can be significant for small teams | k6 or Gatling for load and performance testing — mabl handles functional correctness, not throughput |
What I would do
Practitioner judgment on tool adoption, team onboarding, and when to swap.
If…
I were a QA lead at CloudBooks and owned the regression suite for a product that ships daily — a team of mixed technical ability, constant UI churn from design iterations, and a backlog of broken Selenium tests nobody wants to maintain
I would…
Run a 30-day mabl pilot on one product's smoke suite. Migrate the 20 most-broken Selenium tests first — those are the ones burning the most maintenance time. Measure whether self-healing actually reduces intervention before committing to an enterprise contract. Keep Playwright for the complex multi-step flows that mabl's recorder struggles with. If the pilot shows 30%+ maintenance reduction, the contract justifies itself within a quarter.
If…
I were a test automation engineer at ListRight evaluating AI testing tools for their classified ads platform — large test surface, cross-browser requirements, and a team that codes but wants faster test creation
I would…
Honestly lean toward Playwright with a well-structured page-object model over mabl here. ListRight's team is technical enough that mabl's low-code benefit doesn't land, the pricing opacity is a risk for a cost-conscious NZ business, and Playwright's speed and flexibility would serve complex search and listing flows better. I'd evaluate mabl only if the team wanted to hand off test authoring to business analysts — that's where its recorder genuinely shines over code-based tools.
If…
I were setting up test automation from scratch at a mid-size NZ government agency like PostNZ — public-facing web portals, modest team, limited in-house automation experience, and a mandate to increase regression coverage without hiring senior engineers
I would…
Raise the data residency question first. mabl's SaaS model means test data and session recordings leave NZ infrastructure — that needs explicit sign-off from the Privacy and Security team before piloting. If that clears, mabl is a strong fit: non-technical staff can author tests, self-healing reduces the bus-factor risk of one senior engineer owning the suite, and the CI integration works well with Azure DevOps which most NZ public sector teams run. If data residency blocks it, Testim's on-premise runner option or a Playwright suite with strong documentation are the fallback.
The bottom line: mabl's self-healing is genuinely impressive — but it earns its cost only when test maintenance is already a measurable pain point. If your team isn't drowning in broken tests, you'll pay enterprise pricing for a capability you don't fully need. Pilot first, measure maintenance hours saved, then sign the contract.
Interview questions
Questions you are likely to get if you list mabl on your CV — with what interviewers are really testing for.
What is the difference between mabl's self-healing and a traditional Selenium test that uses XPath locators?
What they’re really testing: Whether you understand how AI-based locator resolution actually works versus just using the marketing term "self-healing" without substance.
Strong answer covers: mabl builds a multi-attribute model of each element (tag, text, position, attributes) and re-resolves the best match at runtime when the original locator fails; Selenium XPath breaks the moment the DOM structure changes; acknowledge that self-healing has a false-positive risk (~10%) where it silently matches the wrong element.
When would you choose Playwright over mabl for a NZ SaaS product, and when would you go the other way?
What they’re really testing: Tool judgement — can you articulate trade-offs without defaulting to "it depends" with no follow-through.
Strong answer covers: Playwright wins when the team is technical and flows are complex (multi-step API + UI); mabl wins when non-technical staff author tests or maintenance overhead is the primary pain point; in a NZ context, mention cost sensitivity — mabl's opaque enterprise pricing is a real barrier for smaller product companies versus Playwright's zero licence cost.
You’re joining CloudBooks’s QA team as a contractor. They run mabl for UI regression and ship to production daily. On your first week you notice 15% of test runs are flagged as flaky. How do you approach this?
What they’re really testing: Systematic diagnosis under pressure and whether you understand the difference between genuine flakiness and self-healing false positives.
Strong answer covers: Use mabl’s pipeline analytics to triage by journey — isolate whether flakiness clusters on specific flows or environments; check self-healing logs to see if elements are being re-resolved to wrong targets; review intelligent wait settings for timing issues; propose a short freeze on new test authoring until root cause is established before raising it in the CloudBooks incident process.
Your mabl tests pass consistently in the mabl cloud runner but fail every time in your Azure DevOps pipeline. The errors are intermittent timeouts. Walk me through how you’d debug this.
What they’re really testing: Whether you know the mabl execution architecture well enough to understand where environment differences can sneak in.
Strong answer covers: Check if the Azure pipeline is calling mabl via the CLI integration and whether the API token and app URL environment variables are set correctly for that environment; compare the base URL being hit (staging vs prod); review the mabl deployment event trigger to confirm the correct build is under test; look at whether the Azure agent’s network can reach the test environment (firewall rules are a common culprit in NZ corporate environments).
How would you structure a mabl test suite for a product with 300+ user journeys to keep it maintainable as the product scales?
What they’re really testing: Architecture thinking — most candidates know how to record a test, fewer know how to design a suite that doesn’t collapse under its own weight.
Strong answer covers: Organise tests into mabl Plans by risk tier (smoke, regression, release) rather than feature area; use shared test steps for repeated flows like login and checkout so a UI change only needs one update; tag tests for environment and browser scope to control parallel execution cost; establish a naming convention from day one so filtering in the mabl dashboard is usable at scale; schedule smoke suite on every deploy and full regression nightly.